Journal profile · Medicine-Medicine (miscellaneous)
MedComm - Biomaterials and Applications
ISSN 2769-643X · Wiley · Australia
MedComm - Biomaterials and Applications: fully open access; APC about USD 2,600; median 115 days to acceptance (66 articles, last 24 months); acceptance rate 54% (journal website); 45 articles in 2025; indexed in Scopus.
Scope
Aims, scope and focus
MedComm - Biomaterials and Applications is published by Wiley. By OpenAlex counts of its recent articles, its largest topics are Nanoparticle-Based Drug Delivery, Hydrogels: synthesis, properties, applications and Bone Tissue Engineering Materials, together about 29.9% of its articles. Its main subfields are Biomedical Engineering. (generated from OpenAlex topic counts and CAS ranking data)
MedComm – Biomaterials and Applications is an online open access journal which aims to publish the pioneer works in all aspects of the intersection of medicine and materials science, including the application of materials in clinical, basic and translational research, emphasizing on the application materials science, biotechnology and nanotechnology for the diagnosis and treatment of human diseases, biomedical applications, and the biological effect and mechanism of materials on human body. Scope and topics: MedComm – Biomaterials and Applications is a multidisciplinary journal and interested in topics including but not limited to materials science, biotechnology, nanotechnology, drug delivery, medicinal chemistry, medical technology, regenerative medicine, diagnostic, theranostics and biomedical device. MedComm - Biomaterials and Applications focuses on the use and the biological effects of materials in medicine practice. Topics of interest include, but are not limited to: Materials in medicine practice Bio-inspired, biomedical and biomolecular materials Organic materials and inorganic materials Engineering Materials Materials and early disease diagnosis Materials and drug delivery system Materials and biotherapy Biological effect of materials Biomaterials and regenerative medicine Materials and translational medicine Biomedical devices Indexing information: CAS: Chemical Abstracts Service (ACS) Directory of Open Access Journals (DOAJ) SCOPUS (Elsevier)
From the journal's Aims & Scope
Research area (LetPub): Medicine-Medicine (miscellaneous)
Editor-in-chief Mohan EdirisinghePublisher website
Editorial board by country: 14 in mainland China (about 37%); most named Mainland China 14, United States 9, United Kingdom 4, South Korea 3, Hong Kong, China 2 (38 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Nanoparticle-Based Drug DeliveryMaterials Science12.8%
- Hydrogels: synthesis, properties, applicationsBiochemistry, Genetics and Molecular Biology8.7%
- Bone Tissue Engineering MaterialsEngineering8.4%
- Nanoplatforms for cancer theranosticsEngineering8.4%
- 3D Printing in Biomedical ResearchEngineering7.3%
- Advanced Drug Delivery SystemsPharmacology, Toxicology and Pharmaceutics6.4%
- Tissue Engineering and Regenerative MedicineMedicine5.8%
- Advancements in Transdermal Drug DeliveryPharmacology, Toxicology and Pharmaceutics3.8%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
CiteScore quartiles (Scopus, June 2026 release)
| Subject | Quartile | Rank | Percentile |
|---|---|---|---|
| Medicine (miscellaneous) | Q1 | 93/466 | 80th |
| Biomaterials | Q2 | 65/146 | 55th |
Scopus ranks journals by CiteScore within each subject: the 75th percentile and above is Q1, then a quartile every 25 points. A different system from the CAS zones.LetPub
Database indexing
ScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
CASPublisher website
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- CiteScore 2026-06
- 6.2LetPub ·
- CiteScore (publisher) 2025
- 6.2Publisher website ·
- SJR 2026-06
- 0.78LetPub ·
- SNIP 2026-06
- 0.65LetPub ·
- h-index
- 18OpenAlex ·
- i10-index
- 33OpenAlex ·
- 2-year mean citedness
- 2.16OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Volume
- Articles per year (publisher) 2025
- 36Publisher website ·
- Downloads per year (publisher) 2025
- 97,985Publisher website ·
Articles by year OpenAlex count · 216 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 58 | 58 | 315 |
| 2025 | 45 | 45 | 373 |
| 2024 | 46 | 46 | 254 |
| 2023 | 46 | 46 | 65 |
| 2022 | 21 | 21 | 1 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
113 daysMedian, submission to acceptance · P25–P75 83 days – 140 days
- Acceptance to online
- median 36 days (100 articles)
- Submission to online
- median 151 days
- Sample
- 66 articles with submission and acceptance dates (96 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 15 weeksLetPub ·
- Acceptance rate (publisher) 2025
- 54%Publisher website ·
- Submission to first decision 2025
- 29 daysPublisher website ·
- Submission to acceptance 2025
- 116 daysPublisher website ·
- Acceptance to publication 2025
- 44 daysPublisher website ·
- Submission to publication (journal-reported)
- about 15 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | EUR 2,254 / GBP 1,912 / USD 2,600 | Yes | CC BY | |
| OpenAlex | USD 0 | — | — | |
| LetPub | USD 2,600 | Yes | — | |
| Publisher website | No APC | — | — |
Other charges and waivers (author guidelines)
- Submission fee
- No submission fee
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare7 items from the author guidelines
- Abstract
- ≤ 250 words
- Keywords
- 3–6
- Manuscript length
- ≤ 6,000 words
- Reference style
- AMA
- First submission
- Free format: the journal's layout is not required
- Highlights
- Required
- Graphical abstract
- Required
Article types accepted11, with length limits
- editorialOriginal article is the full-length report of current research within any area covered in the journal’s scope, and aims to address novel findings and make signi…main text ≤ 1,000 words
- editorialsEditorials are the most important statement and opinions of global opinion leaders in relevant specialties and specially invited by the Editor, but unsolicited …Length not stated
- highlightHighlight aims to point the MedComm - Biomaterials and Applications readership to the latest novel findings published in other high-impact journals. Research Hi…Length not stated
- letterOriginal article is the full-length report of current research within any area covered in the journal’s scope, and aims to address novel findings and make signi…main text ≤ 1,200 words
- opinionOriginal article is the full-length report of current research within any area covered in the journal’s scope, and aims to address novel findings and make signi…Length not stated
- original articleOriginal article is the full-length report of current research within any area covered in the journal’s scope, and aims to address novel findings and make signi…Length not stated
- perspectiveOriginal article is the full-length report of current research within any area covered in the journal’s scope, and aims to address novel findings and make signi…main text ≤ 3,000 words
- research articleOriginal article is the full-length report of current research within any area covered in the journal’s scope, and aims to address novel findings and make signi…main text ≤ 6,000 words
- reviewOriginal article is the full-length report of current research within any area covered in the journal’s scope, and aims to address novel findings and make signi…Length not stated
- systematic reviewOriginal article is the full-length report of current research within any area covered in the journal’s scope, and aims to address novel findings and make signi…Length not stated
- viewpointOriginal article is the full-length report of current research within any area covered in the journal’s scope, and aims to address novel findings and make signi…Length not stated
Policy excerpts from the journal's websiteAuthorship, Conflicts of interest, Data availability, License & copyright, Open access, Peer review, Preprints
- Authorship Authorship
All listed authors should have contributed to the manuscript substantially and have agreed to the final submitted version.
Source ↗Publisher website ·- Conflicts of interest Conflict of Interest Statement
Authors will be asked to provide a conflict of interest statement during the submission process. Any interest or relationship, financial or otherwise that might be perceived as influencing an author's objectivity is considered a potential source of conflict of interest. These must be disclosed when directly relevant or directly related to the work that the authors describe in their manuscript. Pot…
Source ↗Publisher website ·- Data availability Data Sharing and Data Accessibility
Please review Wiley’s policy here. This journal encourages data sharing.
Source ↗Publisher website ·- License & copyright
Licensing: CC BY; author retains copyright; Wiley granted license to publish. Model summary
Accepted papers will be published under CC BY - Creative Commons Attribution License. With the Creative Commons license, the author retains copyright and the public is allowed to reuse the content. The author grants Wiley a license to publish the article and to identify as the original publisher.
Source ↗Publisher website ·- Open access Understanding Open Access
Fees: no submission fees; APCs currently waived. Model summary
As an open access journal, all articles in MedComm – Biomaterials and Applications are freely available to read, download and share immediately on publication.
Source ↗Publisher website ·- Peer review Peer Review and Acceptance
Peer review: single-blind, two reviewers; Editor-in-Chief screens papers before review. Model summary
The acceptance criteria for all papers are the quality and originality of the research and its significance to journal readership. Except where otherwise stated, manuscripts are single-blind peer reviewed by two reviewers. Papers will only be sent to review if the Editor-in-Chief determines that the paper meets the appropriate quality and relevance requirements.
Source ↗Publisher website ·- Preprints
Preprints: articles previously published on preprint servers are considered for review. Model summary
This journal considers article previously published on preprint servers. MedComm - Biomaterials and Applications will consider for review articles previously available as preprints.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Wiley
- Country or region
- Australia
- Language
- English
- ISSN
- 2769-643X
- Society / sponsor
- Sichuan International Medical Exchange & Promotion Association
- Latest issue on the website
- Volume 5, Issue 3 (September 2026)
- Official links
- Journal homepage ↗LetPub
- Submission system ↗Publisher website
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗DOAJ
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about MedComm - Biomaterials and Applications
How long does peer review take at MedComm - Biomaterials and Applications?
Based on the dates recorded on 66 articles published between November 2024 and November 2026 (the last 24 months), the median time from submission to acceptance is 115 days (interquartile range 85–140 days); authors report an average review time of about 15 weeks; the journal's website gives an acceptance rate of 54% (2025). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of MedComm - Biomaterials and Applications?
According to the journal's author guidelines: Abstract: ≤ 250 words; Keywords: 3–6; Manuscript length: ≤ 6,000 words; Reference style: AMA; First submission: Free format: the journal's layout is not required; Highlights: Required; Graphical abstract: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of MedComm - Biomaterials and Applications based?
Of the 38 board members whose country the journal's board page names, 14 (about 37%) are in mainland China; the countries named most often are Mainland China (14), United States (9) and United Kingdom (4). Counted from the institutions listed on the board page; for reference only.
Which databases index MedComm - Biomaterials and Applications?
According to LetPub and DOAJ records, MedComm - Biomaterials and Applications is indexed in Scopus and DOAJ. The journal's website also lists CAS; that list has not been checked against each database.
Is MedComm - Biomaterials and Applications open access, and what is the APC?
MedComm - Biomaterials and Applications is a fully open-access journal. APC about USD 2,600.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .